Faculty at the #Precisionmedicinesympo 🩺!
Happening Now! 🎤 The Precision Medicine Liver Symposium is in full swing packed with dynamic discussions, new data, and expert perspectives driving progress in liver disease management.
Welcome to the #Precisionmedicinesympo ⭐
There’s still time to register for the Thursday Liver Symposium!
Hear from Dr. Naga Chalasani as he dives into cutting-edge topics including PNPLA3, Resmetirom, FGF-21, and GLP-1 analogues—and what they mean for liver disease management.
👉 Register: loom.ly/YkVFD6Y
Join us at the Thursday Liver Symposium for an expert session with Dr. Naim Alkhouri, MD, FAASLD, DABOM — “Event Rate in MASH Cirrhosis Trials by VCTE: Assessment of the Phase 3 Trial Landscape.”
Register: loom.ly/YkVFD6Y
Dr. Rohit Loomba leads Second Annual Thursday Liver Symposium on November 6th - Register Now!: loom.ly/YkVFD6Y @DrLoomba
🔥 Debate Spotlight : Should patients with burnt-out NASH be included in cirrhosis trials?
Don’t miss this thought-provoking session as two leading experts go head-to-head on one of the most important questions in liver research.
👉 Register now: loom.ly/YkVFD6Y
Register now for the Second Annual Thursday Liver Symposium on Thursday, November 6th!
Don’t miss Dr. Rohit Loomba as he presents new data on cT1, MRE, and MRI-PDFF in treatment response. @DrLoomba
👉 Secure your spot now!: loom.ly/FOeLWak
Don’t miss this session at the Thursday Liver Sympo! 📢
Guadalupe Garcia-Tsao, MD, FRCP will break down the key NEJM papers on SLD and cirrhosis, highlighting the latest evidence and what it means for patient care.
👉 Seats are limited—register now at loom.ly/YkVFD6Y
Learn from the experts at the Second Annual Thursday Liver Symposium!
Cutting-edge updates, practical strategies, and leading voices in liver care—all in one event.
Register now: loom.ly/YkVFD6Y
Join us in Washington, DC!
The Second Annual Thursday Liver Symposium takes place November 6th. Don’t miss this opportunity to connect, learn, and advance care in liver disease.
👉 loom.ly/YkVFD6Y
Dr. Rohit Loomba leads the Second Annual Thursday Liver Symposium on November 6th - Register Now!: loom.ly/YkVFD6Y
2nd Annual Precision Liver Symposium retweeted
Kick starting @MetALDconf in San Diego how to diagnose metALD in clinic ? @AjmeraVeeral @AASLDtweets @AmerGastroAssn @QAnstee @AleksanderKrag
2nd Annual Precision Liver Symposium retweeted
Great talk @juanpabloarab on the impact of alcohol use in the natural history of SLD at the @MetALDconf . Assessment of alcohol intake over time should be standardized in clinical practice. @VCU @VCU_Liver @DrLoomba @MarcoArreseMD @rabataller @ArunJSanyalVCU
2nd Annual Precision Liver Symposium retweeted
Pros and cons of current NITs in MetALD. Inflammation, excess weight, alcohol use and low specificity are the main caveats of NITs. Fantastic talk from @MajaThiele at the @MetALDconf ! #LiverTwitter @DrLoomba @AleksanderKrag @EASLedu @EASLnews @MASLDResearch
2nd Annual Precision Liver Symposium retweeted
How to innovate in MetALD clinical trials? @DrLoomba provided relevant considerations for security and endpoints. NITs biomarkers may play a role in early phase studies! @MASLDResearch @f_tavaglione @DrMaralMD @AjmeraVeeral @MonicaTincopa @UCSD_GI #LiverTwitter @MetALDconf
Excessive Alcohol Use and Alcohol Use Disorder in MetALD Trials session discussion with our esteemed panelists!
Thank you to the MetALD Conference faculty for an excellent day of lectures and insightful learning!




























